Fig. 4From: Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitisAnalysis of anti-BCL6 staining (Part 2): MRONJ (BP) vs. OM vs. ORN vs. control. a Labeling index of OCs with nuclear expression of BCL6 (Nuclear BCL6 + OCs/all OCs). b Labeling index of OCs with cytoplasmic expression of BCL6 (Cytoplasmic BCL6 + OCs/all OCs). c Illustrates the ratio of nuclear BCL + OCs to cytoplasmic BCL + OCs. For detailed data see Table 2. MRONJ (BP) medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy, OC osteoclasts, OM osteomyelitis, ORN osteoradionecrosis, BCL6 B-cell lymphoma 6, ROI region of interestBack to article page